Skip to content

FBCT-guided online adaptive radiotherapy for bladder cancer

A phase II study of FBCT-guided online adaptive radiotherapy for bladder cancer

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085767
Enrollment
Unknown
Registered
2024-06-18
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

intervention group:FBCT-guided online adaptive radiotherapy

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Male or female, aged =18 years old; 2. Bladder urothelial carcinoma or urothelial carcinoma as the main component was confirmed by pathology; 3. The ECOG 0 to 2 points; 4. Life expectancy =2 years; 5. Patients are unwilling or unable to undergo radical cystectomy.

Exclusion criteria

Exclusion criteria: 1. There are contraindications to radiotherapy 2. Allergy to CT contrast media; 3. Previous radiotherapy history in the area to be treated 4. Women who were pregnant or planned to become pregnant during the study 5. Poor control of underlying diseases may lead to life-threatening aggravation of underlying diseases after radiotherapy; 6. The investigator determined that inclusion was not appropriate.

Design outcomes

Primary

MeasureTime frame
Qualified rate of target coverage;

Secondary

MeasureTime frame
Local control;Dose differences in organs at risk;Acute adverse events;Late adverse events;

Countries

China

Contacts

Public ContactLiru He

Sun Yat-sen University Cancer Center

helir@sysucc.org.cn+86 136 3136 5597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026